Abstract
Bladder cancer (BC) is the second most common tobacco-related malignancy. Relative to more prominent tobacco-related malignancies, such as cancer of the lung and oropharynx, little is known about the implications of continued tobacco use after the diagnosis of BC. Cessation of tobacco use after the diagnosis of lung or oropharyngeal cancer improves disease-specific recurrence, progression, and survival.1-4 Whether the same is true after the diagnosis of BC is yet to be determined.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
